Literature DB >> 23525475

Downregulation of Polo-like kinase 1 induces cellular senescence in human primary cells through a p53-dependent pathway.

Hee-Jin Kim1, Jung Hee Cho, Jae-Ryong Kim.   

Abstract

Polo-like kinase 1 (PLK1) plays a key role in various stages of mitosis from entry into M phase to exit from mitosis. However, its role in cellular senescence remains to be determined. Therefore, the effects of PLK1 on cellular senescence in human primary cells were investigated. We found that expression of PLK1 decreased in human dermal fibroblasts and human umbilical vein endothelial cells under replicative senescence and premature senescence induced by adriamycin. PLK1 knockdown with PLK1 small interfering RNAs in young cells induced premature senescence. In contrast, upregulation of PLK1 in old cells partially reversed senescence phenotypes. Cellular senescence by PLK1 inhibition was observed in p16 knockdown cells but not in p53 knockdown cells. Our data suggest that PLK1 repression might result in cellular senescence in human primary cells via a p53-dependent pathway.

Entities:  

Keywords:  Cellular senescence; Human primary cells.; Polo-like kinase 1; p53

Mesh:

Substances:

Year:  2013        PMID: 23525475     DOI: 10.1093/gerona/glt017

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  14 in total

1.  Small molecule inhibition of polo-like kinase 1 by volasertib (BI 6727) causes significant melanoma growth delay and regression in vivo.

Authors:  Brian D Cholewa; Mary A Ndiaye; Wei Huang; Xiaoqi Liu; Nihal Ahmad
Journal:  Cancer Lett       Date:  2016-10-25       Impact factor: 8.679

2.  PLK1 inhibition down-regulates polycomb group protein BMI1 via modulation of the miR-200c/141 cluster.

Authors:  Manjari Dimri; Joon-Ho Cho; Mingu Kang; Goberdhan P Dimri
Journal:  J Biol Chem       Date:  2014-12-12       Impact factor: 5.157

Review 3.  Ionizing Radiation-Induced Endothelial Cell Senescence and Cardiovascular Diseases.

Authors:  Yingying Wang; Marjan Boerma; Daohong Zhou
Journal:  Radiat Res       Date:  2016-07-07       Impact factor: 2.841

Review 4.  The role of polo-like kinase 1 in carcinogenesis: cause or consequence?

Authors:  Brian D Cholewa; Xiaoqi Liu; Nihal Ahmad
Journal:  Cancer Res       Date:  2013-11-21       Impact factor: 12.701

5.  Meeting Report: International Symposium on the Genetics of Aging and Life History II.

Authors:  Murat Artan; Ara B Hwang; Seung V Lee; Hong Gil Nam
Journal:  Aging (Albany NY)       Date:  2015-06       Impact factor: 5.682

6.  Pharmacological inhibition of Polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and survival of hamartin and tuberin deficient cells via induction of apoptosis and attenuation of autophagy.

Authors:  Matthildi Valianou; Andrew M Cox; Benjamin Pichette; Shannon Hartley; Unmesha Roy Paladhi; Aristotelis Astrinidis
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

7.  Plk1 inhibition causes post-mitotic DNA damage and senescence in a range of human tumor cell lines.

Authors:  Denise L Driscoll; Arijit Chakravarty; Doug Bowman; Vaishali Shinde; Kerri Lasky; Judy Shi; Tricia Vos; Bradley Stringer; Ben Amidon; Natalie D'Amore; Marc L Hyer
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

8.  Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neck.

Authors:  D Vicky de Boer; Sanne R Martens-de Kemp; Marijke Buijze; Marijke Stigter-van Walsum; Elisabeth Bloemena; Ralf Dietrich; C René Leemans; Victor W van Beusechem; Boudewijn J M Braakhuis; Ruud H Brakenhoff
Journal:  Oncotarget       Date:  2017-05-16

9.  Loss of p21Cip1/CDKN1A renders cancer cells susceptible to Polo-like kinase 1 inhibition.

Authors:  Nina-Naomi Kreis; Frank Louwen; Brigitte Zimmer; Juping Yuan
Journal:  Oncotarget       Date:  2015-03-30

10.  Conserved genes and pathways in primary human fibroblast strains undergoing replicative and radiation induced senescence.

Authors:  Shiva Marthandan; Uwe Menzel; Steffen Priebe; Marco Groth; Reinhard Guthke; Matthias Platzer; Peter Hemmerich; Christoph Kaether; Stephan Diekmann
Journal:  Biol Res       Date:  2016-07-28       Impact factor: 5.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.